Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.61 USD | +2.56% | +8.83% | +4.46% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 648M |
---|---|---|---|---|---|
Net income 2024 * | -115M | Net income 2025 * | -142M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.55
x | P/E ratio 2025 * |
-5
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.48% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 day | +2.56% | ||
1 week | +8.83% | ||
Current month | +8.83% | ||
1 month | -12.40% | ||
3 months | -23.73% | ||
6 months | +40.29% | ||
Current year | +4.46% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.48% | 4 M€ | -5.15% | - | |
0.03% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 9.61 | +2.56% | 375,149 |
24-05-06 | 9.37 | -3.50% | 311,589 |
24-05-03 | 9.71 | +2.00% | 277,184 |
24-05-02 | 9.52 | +2.04% | 555,938 |
24-05-01 | 9.33 | +5.66% | 762,455 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.46% | 648M | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.97% | 23.47B | |
-13.89% | 21.9B | |
-6.22% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- ORIC Stock